--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
Jul 24, 20242024/Q20.000 / 0.000--
Apr 24, 20242024/Q10.000 / 0.000--
Feb 7, 20242023/Q40.000 / 0.000--
US Stock MarketDetailed Quotes
VKTX Viking Therapeutics
- 64.630
- +0.280+0.44%
Close Aug 23 16:00 ET
- 64.700
- +0.070+0.11%
Post 20:02 ET
7.16BMarket Cap-69494P/E (TTM)
65.320High63.019Low2.24MVolume64.050Open64.350Pre Close144.39MTurnover2.14%Turnover RatioLossP/E (Static)110.80MShares99.41052wk High7.78P/B6.77BFloat Cap8.28052wk Low--Dividend TTM104.73MShs Float99.410Historical High--Div YieldTTM3.58%Amplitude0.880Historical Low64.441Avg Price1Lot Size
Viking Therapeutics Key Stats
Viking Therapeutics Q2 2024 Earnings Date
Currency：USDJul 24, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-- | -- | -- | |
| EPS | -0.27 | -0.20 | +0.07 |
| Beat Est. | -41.65% | -5.26% | +25.65% |
Analyst Rating
Aug 16, 2024
Viking Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 11 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Viking Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
